| SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, ... Nature 584 (7821), 457-462, 2020 | 2158 | 2020 |
| The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection MK Maini, C Boni, CK Lee, JR Larrubia, S Reignat, GS Ogg, AS King, ... The Journal of experimental medicine 191 (8), 1269-1280, 2000 | 1166 | 2000 |
| Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection C Boni, P Fisicaro, C Valdatta, B Amadei, P Di Vincenzo, T Giuberti, ... Journal of virology 81 (8), 4215-4225, 2007 | 1156 | 2007 |
| Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells M Haniffa, A Shin, V Bigley, N McGovern, P Teo, P See, PS Wasan, ... Immunity 37 (1), 60-73, 2012 | 861 | 2012 |
| Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells A Bertoletti, A Sette, FV Chisari, A Penna, M Levrero, MD Carli, ... Nature 369 (6479), 407-410, 1994 | 713 | 1994 |
| Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients AT Tan, M Linster, CW Tan, N Le Bert, WN Chia, K Kunasegaran, ... Cell reports 34 (6), 2021 | 710 | 2021 |
| Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. C Ferrari, A Penna, A Bertoletti, A Valli, AD Antoni, T Giuberti, A Cavalli, ... Journal of immunology (Baltimore, Md.: 1950) 145 (10), 3442-3449, 1990 | 672 | 1990 |
| The immune response during hepatitis B virus infection A Bertoletti, AJ Gehring Journal of General Virology 87 (6), 1439-1449, 2006 | 631 | 2006 |
| Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection A Bertoletti, C Ferrari Postgraduate Medical Journal 89 (1051), 294-304, 2013 | 622 | 2013 |
| Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms GJM Webster, S Reignat, MK Maini, SA Whalley, GS Ogg, A King, ... Hepatology 32 (5), 1117-1124, 2000 | 621 | 2000 |
| Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. C Boni, A Bertoletti, A Penna, A Cavalli, M Pilli, S Urbani, P Scognamiglio, ... The Journal of clinical investigation 102 (5), 968-975, 1998 | 591 | 1998 |
| Therapeutic strategies for hepatitis B virus infection: towards a cure GC Fanning, F Zoulim, J Hou, A Bertoletti Nature reviews Drug discovery 18 (11), 827-844, 2019 | 542 | 2019 |
| Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage C Dunn, M Brunetto, G Reynolds, T Christophides, PT Kennedy, ... The Journal of experimental medicine 204 (3), 667-680, 2007 | 539 | 2007 |
| Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for … GJM Webster, S Reignat, D Brown, GS Ogg, L Jones, SL Seneviratne, ... Journal of virology 78 (11), 5707-5719, 2004 | 520 | 2004 |
| Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection MK Maini, C Boni, GS Ogg, AS King, S Reignat, CK Lee, JR Larrubia, ... Gastroenterology 117 (6), 1386-1396, 1999 | 504 | 1999 |
| Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection OW Ng, A Chia, AT Tan, RS Jadi, HN Leong, A Bertoletti, YJ Tan Vaccine 34 (17), 2008-2014, 2016 | 484 | 2016 |
| Lamivudine treatment can overcome cytotoxic T‐cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy C Boni, A Penna, GS Ogg, A Bertoletti, M Pilli, C Cavallo, A Cavalli, ... Hepatology 33 (4), 963-971, 2001 | 483 | 2001 |
| Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections A Bertoletti, MM D'Elios, C Boni, M De Carli, AL Zignego, M Durazzo, ... Gastroenterology 112 (1), 193-199, 1997 | 476 | 1997 |
| Update of the statements on biology and clinical impact of occult hepatitis B virus infection G Raimondo, S Locarnini, T Pollicino, M Levrero, F Zoulim, AS Lok, ... Journal of hepatology 71 (2), 397-408, 2019 | 474 | 2019 |
| Adaptive immunity in HBV infection A Bertoletti, C Ferrari Journal of hepatology 64 (1), S71-S83, 2016 | 474 | 2016 |
Adam J. GehringToronto Centre for Liver DiseaseEmail verificata su uhnresearch.ca